drug

Prednisolone

MeSH D011239
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Haukeland University Hospital
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

2
The Norwegian Prednisolone in Early Psychosis Study
NCT03340909Phase 2Terminated
Prednisolone Addition for Patients With Recent-onset Psychotic Disorder
NCT02949232Phase 4Terminated

KOLs & investigators

4
Solveig Klæbo Reitan, MD, PhDKOL score 20
Iris E.C. Sommer, Prof. Dr.KOL score 16
Erik Johnsen, MD, PhDKOL score 15
Helle Schøyen, MD, PhD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Haukeland University Hospital
company
trial
The Norwegian Prednisolone in Early Psychosis Study
PHASE2
trial
Prednisolone Addition for Patients With Recent-onset Psychotic Disorder
PHASE4
trial
indication
Schizophrenia
indication
Psychosis
indication
Immune Suppression
indication
Schizophreniform Disorder
indication
KOL
Solveig Klæbo Reitan, MD, PhD
KOL score 20
person
Iris E.C. Sommer, Prof. Dr.
KOL score 16
person
Erik Johnsen, MD, PhD
KOL score 15
person
Helle Schøyen, MD, PhD
KOL score —
person